Bill · S. 2760· Senate(119-S-2760)
Reducing Hereditary Cancer Act of 2025
- Introduced
- 9/10/2025
- Last activity
- 9/10/2025 — Read twice and referred to the Committee on Finance.
- Sponsored by
- Lisa Murkowski
- Cosponsors
- - 0 - 1
- Introduced
- In Committee
What this bill would do
The Reducing Hereditary Cancer Act of 2025 updates the Social Security Act to expand coverage for people at risk of inherited cancers. It provides for germline mutation testing for those with a personal or family history of cancer gene mutations or suspicious histories. The bill also covers risk-reducing preventive surgeries based on clinical guidelines. Additionally, it requires the Secretary to increase frequency limitations for evidence-based screenings for individuals with a confirmed hereditary cancer gene mutation.
Yes· 3 of 11
Would people over 65 be better off under this?+9
Directly benefits Medicare recipients by expanding coverage for cancer-related genetic services.
Would retired people be better off under this?+9
Seniors and retirees utilizing Medicare gain essential new cancer prevention benefits.
Would women be better off under this?+8
Significantly impacts women through improved coverage for breast and gynecological cancer screenings and surgeries.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Access to Genetic Testing: Individuals with a personal or family history of hereditary cancer gene mutations or suspicious histories can get germline mutation testing under Section 2(a).
-
Risk-Reducing Surgeries: People identified via genetic testing who could benefit from surgery to reduce their cancer risk will have those surgeries considered reasonable and necessary for treatment under Section 3(a).
-
Increased Screening Frequency: People with a confirmed hereditary cancer gene mutation can receive evidence-based screenings—such as colonoscopies, PSA testing, breast screening MRI, and mammography—at an increased frequency, at least annually, as per Section 4(a).
Potential Negative Impacts for People
- Coverage Limitations: Under Section 2(b), the bill lists germline mutation testing as an item that may be subject to limitations if performed more than once for an individual.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Retirees+9Good For Seniors+9Good For Women+8Good For Men+7Good For Middle Aged+7Good For Low Income Households+6Good For Middle Class Households+6Good For High Income Households+4
- Healthcare
- Improves Healthcare Access+8Increases Medicare Funding+5
- Social Issues And Justice
- Improves Social Security+5
- 9/10/2025
- Read twice and referred to the Committee on Finance.
- 1 Cosponsor added.
- Introduced in Senate
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Elissa SlotkinDemocrat · Michigan